Notch Therapeutics Closes $85M Series A Financing

– Notch Therapeutics is a Vancouver, BC-based biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for cancer.
– Company closed an U.S. $85m Series A financing.
– The round was led by an exclusively healthcare-focused investment fund with participation from existing investors Allogene Therapeutics, Inc., Lumira Ventures, and CCRM Enterprises Holdings Ltd., an affiliate of Centre for Commercialization of Regenerative Medicine (CCRM); along with new investors EcoR1 Capital, Casdin Capital, Samsara BioCapital, and Amplitude Ventures.